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Abstract
Background: Intra-tumour heterogeneity (ITH) is the result of ongoing evolutionary change within each cancer.
The expansion of genetically distinct sub-clonal populations may explain the emergence of drug resistance and if
so would have prognostic and predictive utility. However, methods for objectively quantifying ITH have been
missing and are particularly difficult to establish in cancers where predominant copy number variation prevents
accurate phylogenetic reconstruction owing to horizontal dependencies caused by long and cascading genomic
rearrangements.
Results: To address these challenges we present MEDICC, a method for phylogenetic reconstruction and ITH
quantification based on a Minimum Event Distance for Intra-tumour Copynumber Comparisons. Using a
transducer-based pairwise comparison function we determine optimal phasing of major and minor alleles, as well
as evolutionary distances between samples, and are able to reconstruct ancestral genomes. Rigorous simulations
and an extensive clinical study show the power of our method, which outperforms state-of-the-art competitors in
reconstruction accuracy and additionally allows unbiased numerical quantification of ITH.
Conclusions: Accurate quantification and evolutionary inference are essential to understand the functional
consequences of ITH. The MEDICC algorithms are independent of the experimental techniques used and are
applicable to both next-generation sequencing and array CGH data.
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Background
The study of intra-tumour genetic heterogeneity (ITH) is now a major focus of cancer genomics research
[1–12] due to its potential to provide prognostic information [13–15] and to explain mechanisms of drug
resistance [16–19]. Quantifying heterogeneity and understanding its aetiology crucially depends on our
ability to accurately reconstruct the evolutionary history of cancer cells within each patient. In many
cancers, such as high-grade serous ovarian cancer (HGSOC), most of this heterogeneity is not reflected in
point mutations but in genomic rearrangements and endoreduplications that lead to aberrant copy number
(CN) profiles [20, 21]. In these cases tree inference is hindered by unknown phasing of parental alleles,
horizontal dependencies between adjacent genomic loci and the lack of curated CN profile databases to use
as a reference for probabilistic inference. Therefore heterogeneity and evolutionary divergence are typically
quantified using ad-hoc thresholds [19] and tree inference is often done subjectively [11]. Approaches
developed to address this problem include Greenman et al. [22], a graph theoretical approach on signed
reversals to order rearrangement events, but this requires detailed annotation of rearrangements in the
data that may not be available, and the algorithm does not generally infer global trees representing cancer
evolution within a patient. The TuMult algorithm [23] deals with underlying computational complexity by
considering only breakpoints — locations on the genome where the CN changes — and by using total CN
without phasing of parental alleles. While simplifying the computational problem, this approach discards
potentially informative data.
Our aim is to establish numerical quantification of ITH per patient from CN profiles that can routinely be
acquired from clinical samples. To this end, we have developed MEDICC (Minimum Event Distance for
Intra-tumour Copy-number Comparisons), a method for accurate inference of phylogenetic trees from
unsigned integer CN profiles. MEDICC specifically addresses the following challenges associated with
CN-based phylogeny estimation. i) It makes use of the full CN information across both parental alleles by
estimating an optimal phasing of CN variants using the evolutionary information. ii) It deals with
horizontal dependencies between adjacent genomic loci and with multiple overlapping events by using
efficient heuristics. It can therefore work on complete genomic profiles instead of breakpoints which allows
the reconstruction of ancestral genomes. iii) It implements statistical tests for evolutionary rates, tests for
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phylogenetic structure and tests for the relationship between clonal subpopulations to provide informative
summary statistics for the reconstructed evolutionary histories and ITH.
We developed MEDICC and successfully applied it to the analysis of a novel dataset of 170 CN profiles of
patients undergoing neo-adjuvant chemotherapy for HGSOC as described in our accompanying clinical
study (Schwarz et al. 2013 in prep.). In the following we first give a more detailed description of the data
and problems that MEDICC addresses. We then introduce the MEDICC modelling framework that guides
all steps of the algorithm and which is then explained in detail. We finish with a demonstration of
MEDICC on a real-world example of a case of endometrioid cancer and give simulation results that
compare it to competing methods.
Results and Discussion
MEDICC was designed to work on human integer CN profiles that can routinely be obtained from single
nucleotide polymorphism (SNP) arrays [24] or paired-end sequencing [25, 26]. In both cases DNA content
is quantified relative to a diploid normal in windows along the genome. Point mutations help to distinguish
the two parental alleles and the resulting profile comprises two vectors of integer CNs, representing the
absolute number of copies of that particular genomic segment in both alleles; however the phasing of those
CNs to the two parental alleles is unknown, unless two SNPs happen to be on the same read or other
external linkage information is available [11]. Consequently, by definition (and for each genomic segment
independently), the larger of the two CNs is termed the major and the other the minor CN, without any
information about which CNs belong together on the same allele (Figure 1 left). Without resolving this
ambiguity, tracing of individual events is not possible.
Another challenge is horizontal dependency in CN profiles. In contrast to nucleotide substitution models
where sites in a sequence are modelled as independent and identically distributed (iid) [27], CN events
often overlap and range across many adjacent genomic regions and thereby introduce horizontal
dependencies that influence estimation of evolutionary divergence.
Given multiple such evolutionarily-related CN profiles, for example from distinct primary and metastatic
sites of the same patient, phylogenetic inference in MEDICC then involves three steps: (i) allele-specific
assignment of major and minor CNs, (ii) estimation of evolutionary distances between samples followed by
tree inference and (iii) reconstruction of ancestral genomes (Figure 1). All three steps are guided by a
minimum evolution criterion. Similar to early edit-distances for sequence analysis [28], MEDICC counts
the number of genomic events needed to transform one CN profile into another and searches for the tree
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that minimises this criterion.
MEDICC reconstructs evolutionary histories via a minimum evolution criterion
We model the evolution of genomic rearrangements through the following set of events that have an
observable effect on CN profiles: terminal and interstitial deletions, as well as unbalanced translocations,
are single deletion events; tandem and inverted duplications are single amplification events; and breakage
fusion bridges are dual events involving a duplication and a deletion [22]. We use a finite-state automaton
representation of genomic profiles and finite-state transducers [29] for modelling and efficient computing of
the minimum-event distance based on these genomic events (Figure 2A). Before going through the three
steps of the reconstruction process in detail it is necessary to introduce some terminology; for a more
thorough introduction into transducer theory see [29–31] and references therein.
The MEDICC modelling framework
MEDICC models diploid genomic CN profiles as sequences over the alphabet Σ = {0, . . . ,K, “X”}, where
{0, . . . ,K} represent integer CNs (K is the maximum haploid CN) and “X” is a special character that
separates the two alleles on which events can happen independently. For example, the profile
1123002X0122002 represents a chromosome with 7 regions distinguished, with the first region present in
one copy on one allele and absent in the other allele; the second region present in one copy on each allele;
and so on up to the seventh region present in two copies on each allele. This means that MEDICC deals
with a maximum total CN of 2K in a diploid genome. By default 2K = 8 which is the upper end of the
dynamic range of SNP arrays, but the alphabet can be extended easily without changing the
implementation. In this manuscript the terms “sequence” and “(CN) profile” are used interchangeably.
CN profiles are implemented as acceptors, weighted finite-state automata (FSA) that can contain a single
or multiple such profiles. The minimum-event distance is implemented as a weighted finite-state transducer
(FST, [29]). FSTs are an extension of FSAs with input and output symbols — like pair-HMMs they emit
or accept two sequences simultaneously, meaning they model the events transforming on sequence into
another. Both FSAs and FSTs can be equipped with weights from a semiring, enabling calculations to be
weighted according to some importance criterion. One of the most common semirings is the real semiring
(e.g. the weights represent probabilities), where weights are multiplied along a path in the automaton and
the total weight of a sequence (or pair of sequences) is the sum (total probability) over all possible paths
generating that sequence. Equally popular is the tropical semiring, also known as the Viterbi path, where
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weights are summed along a path and the total weight is the minimum across all those paths. In this case
weights are often “penalties” or negative log-probabilities for taking a certain path, similar to classical
pairwise sequence alignment in which mismatches and indels are penalised with additive fixed scores.
MEDICC uses the tropical semiring for computing the minimum event distance, but the modularity of the
framework allows us to smoothly transition to probabilities at a later stage by switching semirings without
changing the algorithm. In this tropical semiring a FST T1 then assigns a score to two sequences
(represented as acceptors) x and z via
T1[x, z] = min
p∈P
∑
i
w(p, i).
where P is the set of all possible paths through the FST in which the input and output symbols match
with the sequences x and z and w(p, i) is the weight of that path at position i in the sequence. No score is
returned for a pair of sequences for which no valid path in T1 exists. This leads to the definition of the
minimum-event distance, which governs all three steps of the reconstruction process.
Constructing the minimum-event distance for CN profiles
Figure 2B shows the one-step transducer T1 that we use to model single amplifications and deletions of
arbitrary length and that counts one event each time the amplification or deletion state is entered. This is
analogous to an affine gap cost model in classical sequence alignment [32]. T1[x, z] therefore assigns to each
pair of sequences (x, z) the minimum number of events necessary to transform one sequence into another.
At this point, however, not all possible CN scenarios have a valid path (e.g. one event can amplify “1” to
“2” but not “1” to “3”). To include all possible changes across multiple events, T1 is composed K times
with itself [30]. In essence, composition describes the chaining of FSTs, where the total weight of the
composed transducer is the total minimum score from the input sequence x via intermediate sequences yi
to the target sequence z:
T [x, z] = (T1 ◦ ... ◦ T1)[x, z]
= min
y1,...,yK−1
(T1[x, y1] + . . .+ T1[yK−1, z])
This gives rise to the FST T that strictly adheres the modelled biological constraints such as no
amplification from zero. We call T the tree transducer: these biological constraints give it a direction, and
it is not guaranteed to return a distance for any pair of CN profiles.
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As we are interested in the minimum evolutionary distance between any two sequences x and z via their
last common ancestor (LCA) y, the final distance FST D is formed by composing T with its inverse
(Figure 2C, [33]), such that D computes the distance from a leaf node to the LCA (T−1) and back (T ) to
the other leaf node:
D[x, z] = (T−1 ◦ T )[x, z]
= min
y
(
T−1[x, y] + T [y, z]
)
In the real semiring, and equipped with probabilities, this would be analogous to classical phylogenetic
reconstructions where a reversible model of sequence evolution is used to compute the likelihood of the
subtree containing sequences x and z as the products of the individual likelihoods of seeing x and z given
their ancestor y and summing over all y [34]. In our case, D equivalently computes the minimum number
of events from x to z via their LCA. This distance is symmetric and is guaranteed to yield a valid distance
for any pair of sequences. In the rest of the paper, “distance” refers to this minimum-event distance, unless
stated otherwise.
MEDICC therefore computes an evolutionary distance between two genomes based on a minimum
evolution criterion via their closest possible LCA. Due to composition of the tree transducer T with its
inverse, the resulting distance D is a dissimilarity score that represents (the logarithm of) the shortest-path
approximation to a positive-semidefinite kernel score [35, 33]. This means that computing the evolutionary
distances between samples automatically places these samples in a high-dimensional evolutionary space,
where in addition to distances we gain information about their relative position and angles. We term this
space the mutational landscape, on which we can directly apply explorative analyses like PCA, classification
with support-vector machines and other machine learning techniques [36]. We use OpenFST, an efficient
implementation of transducer algorithms [37] to achieve exact distance computation in quadratic time.
Following the minimum evolution principle, the overall objective is to find a tree topology including
ancestral states that minimises the total tree length, i.e. the total number of genomic events along the tree.
In the following we will describe how MEDICC achieves this in its three step process.
Step 1: Evolutionary phasing of major and minor CNs
As CN-changing events can independently occur on either or both of the parental alleles, the allele-specific
assignment, or phasing, of major and minor CNs heavily influences the minimum tree length objective. We
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use the evolutionary information between samples to solve these ambiguities. Using our distance measure
we can choose an optimal phasing between a pair of diploid profiles that minimises the pairwise distance
between them (Figure 3A). This respects the distinct evolutionary histories of both alleles and finds a
phasing scenario in which the evolutionary trajectories between both haploid pairs are minimal. To achieve
this, a diploid profile is represented as a single sequence in which the allele boundaries are marked by a
separator character as described above. From each pair of major and minor input sequences we can
generate up to 2L such concatenated sequences, where L is the length of the input profile (both alleles have
the same length). This number is too large to enumerate exhaustively, so in order to achieve a compact
representation of diploid profiles we make use of a context-free grammar (CFG). Our implementation is
related to the use of CFGs to model RNA structures, where paired residues in stem regions are not
independent [32].
In our CN scenario a CFG represents different allele phasing choices (see Figure 3B right). At every
position in the diploid profile we have a choice of using the major as the first allele and the minor as the
second or (“|”) vice versa (Figure 3B left). Each possible parse tree of the CFG then corresponds to one
phasing scenario out of the 2L possibilities. When the distance FST reads the separator it is forced to
return to the match state (initial state), thus guaranteeing that the total distance to another profile equals
the sum of the distances of the two alleles with no events spanning different alleles. We represent CFGs
algorithmically by pushdown-automata in the FST library [38].
While this approach works well for finding phasing scenarios that minimise the distance between one pair
of profiles, we aim to find phasing scenarios that jointly minimise the distances between all profiles in the
dataset. To reduce the computational complexity of this task it is necessary to employ a heuristic.
MEDICC searches for the single profile that has minimum sum of distances to all sample profiles, that is,
the geometric median, through an iterative search. This centre profile is then compared again to each
individual profile and the shortest path algorithm yields the choice of phasing that minimises the distance
between each profile and the centre. While this is not guaranteed to return a globally optimal phasing
scenario, it has proven to perform very well in practise.
Step 2: Distances and tree reconstruction
Once the alleles have been phased, pairwise evolutionary distances between samples can be computed as
the sum of the pairwise distances between both alleles. MEDICC then uses the Fitch-Margoliash algorithm
[39] for tree inference from a distance matrix with or without clock assumption. A test of clock-like events,
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available using functionality in the accompanying R package MEDICCquant, allows us to determine which
tree reconstruction algorithm is most appropriate (see the section on quantification of ITH).
Step 3: Ancestral reconstruction and branch lengths
From this point on we keep the topology of the tree fixed, and traverse from its leaves to the root to infer
ancestral CN profiles and branch lengths. Ancestral reconstruction is possible because cancer trees are
naturally rooted by the diploid normal from which the disease evolved. Reconstructing ancestral genomes
allows us to investigate e.g. the genomic makeup of the cancer precursor, the LCA of all cancer samples in
the patient. Events that across patients frequently occur between the root of the tree and the precursor are
likely driver events of cancer progression. Ancestral reconstruction also determines the final branch lengths
of the tree. MEDICC infers ancestral genomes for each allele independently using a variant of Felsenstein’s
Pruning algorithm [27]. In traditional ancestral reconstruction the total score (likelihood/parsimony score)
of the tree is computed in a downward pass towards the root and ancestral states are then fixed in a second
upward pass, successively choosing the most likely/most parsimonious states.
In our scenario, the algorithm begins by composing each of the n terminal nodes with the tree transducer
T , which yields n acceptors holding all sequences reachable from that terminal node and their respective
distances. When the first two terminal nodes are joined in their LCA the corresponding acceptors are
intersected. The resulting acceptor contains only those profiles that were contained in both input acceptors
and their corresponding weights are set equal to the sum of the weights of the profiles in the input
acceptors. In a probabilistic framework the resulting acceptor is equivalent to the conditional probability
distribution P (subtree(x, z) | LCA y) = P (x|y)P (z|y) for each possible LCA, where the sum of distances
again is replaced by the product of the conditional probabilities of seeing a leaf node given its ancestor.
This intersection will still contain the vast majority of all possible profiles, but each with a different total
distance, and without those that are prohibited by biological constraints. For example, the ancestor cannot
have a CN of zero at a position where at least one of its leaf nodes has CN > 0, as amplifications from zero
are not allowed.
Because after phasing each leaf node is represented by an acceptor containing exactly one diploid sequence,
computing this set of possible ancestors is computationally feasible. However, because during tree traversal
we need to compose these sets of possible profiles repeatedly with the tree transducer T , the result would
increase in size exponentially because it has to account for all possible events of arbitrary length at each
position in all sequences. Therefore during tree traversal, when two internal nodes have to be joined in
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their LCA, MEDICC reduces them to a single sequence by choosing those two sequences with smallest
distance to each other. This fixes the profiles for those two internal nodes. This procedure is continued
until all internal nodes are resolved. Once all ancestral CN profiles have been reconstructed the final
branch lengths are simply the distances between the nodes defining that branch in the tree.
MEDICC improves phylogenetic reconstruction accuracy
We assessed reconstruction accuracy using simulated data generated by the SimCopy R package [40] (see
Methods). Random coalescent trees were generated with APE [41]. To create an unbiased simulation
scenario, genome evolution was simulated using increasing evolutionary rates on the sequence level using
five basic genomic rearrangement events: deletion, duplication, inverted duplication, inversion and
translocation (for details see Methods). Once the simulations were complete, CNs were counted for each
genomic segment and these CN profiles were used for tree inference using the following three methods: i)
BioNJ [42] tree reconstruction on a matrix of euclidean distances computed directly on the CNs, ii)
breakpoint-based tree-inference using the TuMult software [23] and iii) MEDICC. TuMult additionally
requires array log-intensities as input. In order to keep the comparisons unbiased, noiseless log ratios
simulating CGH array intensities for TuMult were directly computed from the CN profiles. To assess the
relative abilities of the methods to correctly recover the evolutionary relationships of the simulated CN
profiles, reconstruction accuracy was measured in quartet distance [43] between the true and the
reconstructed tree. Quartet distance was chosen as it only considers topological differences; branch lengths
have widely different meanings in the methods tested and as such are not comparable.
This simulation strategy is based on basic biological principles, independent of the methods compared and
a priori does not favour any of them. All simulations were repeated to cover a wide parameter range,
yielding qualitatively similar results.
The simulation results clearly show the improvement in reconstruction accuracy of MEDICC over naive
approaches (BioNJ on Euclidean distances) and competing methods (TuMult) (Figure 4A). In general,
reconstruction accuracies increase with increasing evolutionary rates. Especially when the amount of
phylogenetic information is limited, MEDICC outperforms other methods by a significant margin. This
may be because of two reasons: firstly, in contrast to other methods MEDICC is capable of phasing the
parental alleles, thereby making much more effective use of the phylogenetic information compared to
methods that work on total CN alone. Secondly, due to efficient and accurate heuristics, MEDICC can deal
with the horizontal dependencies imposed by overlapping genomic events of arbitrary size and accurately
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computes distances between them.
Evolutionary comparisons with MEDICC allow quantification of tumour heterogeneity
As described earlier, the matrix of pairwise distances inferred by MEDICC is the logarithm of a rational
kernel matrix [35, 33] which maps samples to a high-dimensional mutational landscape. We reduce the
dimensionality of this landscape through kernel principal components analysis [44] where we can use
spatial statistics to derive numerical measures of ITH for each patient.
Intra-tumour heterogeneity is a loose concept that describes the amount of genomic difference between
multiple cells or samples of the same tumour. Two types of heterogeneity often of interest are spatial and
temporal heterogeneity. For example, spatial differences might be observed from separate biopsies of a
primary cancer and a distant metastasis. Other changes may occur between different time points, for
example before and after chemotherapy. Average distances between subsets of samples might be computed
by any method that returns dissimilarities between samples by simple averaging. However, as clinical
datasets are noisy, more robust measures of distances between aggregated subsets of samples are desirable.
Temporal heterogeneity
We define temporal heterogeneity as the evolutionary distance between the average genomic profiles
between any two time points (e.g. at biopsy before chemotherapy and at surgery after chemotherapy in the
case of neo-adjuvant treatment). In the mutational landscape (see above) we are able to directly compute
the centre of mass of a set of genomic profiles (which would not be possible by working with distances
alone). We can then define temporal heterogeneity as the distance between the centres of mass of the
samples from those two time points (Figure 5D). The advantage of this approach is that we can use robust
measures of the centre of mass (e.g. ignoring the single most distant point) to estimate temporal
heterogeneity. It should be noted that this general approach can be used for determining distances between
any partitions of the samples in the dataset, for example between groups of samples taken from different
organs as a measure of spatial heterogeneity.
The clonal expansion index
Other complex aspects of ITH that cannot be easily derived from distances alone include the ability of a
tumour to undergo clonal expansions [16]. The model here is that if the majority of cancer cells are subject
to strong selection pressure, such as from chemotherapy, minor subclones with a distinctive selective
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advantage may repopulate. This subpopulation would be expected to coalesce early and will show a greater
than expected divergence (relative to neutral evolution) from other remaining clones. This model is similar
to analyses of clonality in bacterial populations [45]. Traditional tests for deviation from a neutral
coalescent are typically based on single polymorphic sites and often require information about the number
of generations [46]. As such information is not available for clinical cancer studies, we therefore make a
spatial argument about clonal expansions. We assume that due to the large population sizes of cancer cells,
genetic drift is not significant. In a setting of neutral evolution where all sequences have essentially the
same fitness, sequences randomly move across the mutational landscape leading to a uniform distribution
of sequences in that space (Figure 5A) with no selective sweeps or clonal expansions. On the contrary, if
strong selective pressure favours specific mutations (Figure 5B), sequences are more likely to survive and
be sampled from the favoured regions leading to local clustering of sequences on the mutational landscape
(Figure 5C).
Besag’s L(r) [47], a variance-stabilised transformation of Ripley’s K(r), [48] is a function used in spatial
statistics to test for non-homogeneity, i.e. spatial clustering, of points in a plane. λK(r) describes the
expected number of additional random points within a distance r of a typical random point of an
underlying Poisson point process with intensity λ. The empirical estimate of Ripley’s K for n points with
pairwise distances dij and average density λˆ is defined as
Kˆ(r) =
1
λˆn
∑
i 6=j
I(dij < r),
where I is the indicator function. In case of complete spatial randomness (CSR), the expectation of K(r) is
pir2. Besag’s L is the transformation L(r) =
√
K(r)/pi thereof and is under CSR in expectation linear in r.
Therefore plotting r − Lˆ(r) can be used as a graphical indication of deviation from CSR. We use a
simulation approach to estimate significance bands for L(r) [49].
The clonal expansion index CE for a dataset (typically samples taken from a single patient) is then defined
as the maximum ratio between the distance of the observed L-value (Lo(r)) and the theoretical L-value
under CSR (Lt(r)) and one-half the width of the two-sided simulated significance band C(r)u (u for upper
significance band):
CE = max
r
( |Lo(r)− Lt(r)|
Cu(r)− Lt(r)
)
(1)
A value of CE < 1 therefore suggests CSR in the point set, whereas a CE value > 1 indicates local spatial
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clustering. We conducted coalescence simulations to confirm that the clonal expansion index distinguishes
between trees with normal and elongated branch lengths between populations (black and red distributions,
Figure 4B).
Testing for star topology and molecular clock
Tree reconstruction methods may include positive or negative assumption of a molecular clock which will
significantly influence the reconstruction accuracy. It is of particular interest in cancer biology whether
evolution is governed by constant or changing rates of evolutionary change. Furthermore, it is still debated
whether disease progression follows a (structured) tree-like pattern of evolution or if subpopulations are
emitted in radial (star-like) fashion from a small population of stem-like progenitors (see [50]).
We implement two tests for tree-likeness and molecular clock in the MEDICCquant package to help answer
these questions. We model genomic events x as generated from a Poisson process with rate ρ. The
expected number of events is then linear in time: E[X] = ρt. Assuming ρ = 1, where the process is not
time-calibrated, the observed distance Xˆ is the maximum likelihood estimate (MLE) for the time of
divergence. Under asymptotic normality of the MLE we have that Xˆ ∼ N(X,X). Given a star topology
we find optimal branch lengths that minimise the residual sum of squares between the optimised distances
xopti and the measured pairwise distances Xˆi for branch i. Under the null hypothesis of star-like evolution
this sum of squares
RSSstar =
n(n−1)/2∑
i=1
(
xopti − Xˆi
)
√
Xˆi
2
is then χ2-distributed with n(n− 1)/2− n degrees of freedom, where n is the number of samples studied,
i.e. the number of leaves in the tree (Tim Massingham, pers. communication).
An analogous procedure can be used for testing whether a tree follows a molecular clock hypothesis, in
which it exhibits constant evolutionary rates along all branches. In this case the distances of all leaf nodes
from the diploid should be the same. We measure the deviation of the branch lengths from the diploid
from their mean (µ(Xˆ)) by
RSSclock =
n∑
i=1
(
µ(Xˆ)− Xˆi
)
√
Xˆ
Because branch lengths do not need to be optimised to a specific topology, and we are only considering
distances to the diploid, the distribution in this case has n− 1 degrees of freedom.
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Progression and heterogeneity in a case of metastatic endometrioid adenocarcinoma
In the following section we demonstrate MEDICC on a case from the CTCR-OV03 clinical study [51]. This
case had advanced endometrioid ovarian carcinoma and was treated with platinum-based neoadjuvant
chemotherapy. After three cycles of chemotherapy the patient had stable disease based on RECIST
assessment, pre- and post-chemotherapy CT imaging and a 92% reduction of the tumour response marker
CA125. She then underwent interval debulking surgery but had residual tumour of > 1cm at completion.
After six moths she progressed with platinum-resistant disease and died one month later.
Out of 20 biopsy samples 18 satisfied quality control for > 50 tumour cellularity and array quality. The
dataset included 14 omentum samples, two samples from the vaginal vault (VV) and two samples from the
external surface of the bladder (BL). The BL and VV samples were taken prior to chemotherapy and the
omental samples were collected at interval-debulking surgery after three cycles of chemotherapy.
All samples were CN profiled with Affymetrix SNP 6.0 arrays and segmented and compressed using
PICNIC [24] and CGHregions [52]. Pairwise evolutionary distances between all samples were estimated
with MEDICC. The distance distribution was tested for the molecular clock hypothesis using
MEDICCquant and showed strong non-clock like behaviour (p = 2.89x10−14, Figure 6A). Tree
reconstruction was performed by MEDICC using the Fitch-Margoliash algorithm [39]. MEDICCquant
detected a high degree of clonal expansion (CE = 1.24) as can be seen in the strong spatial clustering of
samples on the mutational landscape (Figure 6B). MEDICC counted a median of 204 genomic events
relative to the diploid and a median of 146 between all pairwise comparisons. Tree reconstruction showed
good support values for the omental and BL/VV subclades, suggesting strong spatial heterogeneity. The
patient also showed strong temporal heterogeneity, as there were large evolutionary distances between
samples before and after neoadjuvant chemotherapy (temporal heterogeneity index 3.78, Figure 6B).
However, temporal and spatial heterogeneity in this case are indistinguishable because the BL/VV samples
coincide with the biopsy samples, whereas all omentum samples were taken at surgery.
Ancestral reconstructions using MEDICC showed loss-of-heterozygosity (LOH) events on chromosome 17q
(see internal node profiles in Figure 6A) that often coincide with deleterious mutations in BRCA2 and
TP53 [53]. The most prominent contributors to the clonal expansions of the subgroup surrounding sample
S01 seemed to be chromosomal amplifications on chromosomes 6, 8, 11 and 14; as well as LOH on
chromosome 15. We also detected large LOH events on chromosomes 4, 5, 9, 10, 13, 14, 16 and 17 (Figure
6C).
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Conclusions
While significant progress has been made recently to understand tumour heterogeneity through extensive
multiple sampling studies and experimental efforts, few algorithms have been developed to target the
specific questions raised by such datasets. MEDICC is our contribution to better reconstruct the
evolutionary histories of cancer within a patient and propose unbiased quantification of heterogeneity and
the degree of clonal expansion.
We have shown the success of these efforts in simulations and their utility in the example discussed in this
article. Further examples that also elaborate on the connection between clonal expansion and heterogeneity
and patient outcome can be found in our extensive clinical study (Schwarz et al 2013, in prep.).
As discussed above we attribute the increase in reconstruction accuracy mainly to two factors. First,
MEDICC makes efficient use of the available phylogenetic information by phasing parental alleles using the
minimum evolution criterion, which has to our knowledge not been attempted before. Second, MEDICC
models actual genomic events that change CN and incorporates biological constraints such as loss-of
heterozygosity, which is not the case in breakpoint-based approaches.
The loss of reconstruction accuracy of TuMult relative even to naive approaches using Euclidean distances
is most likely due to the fact that TuMult was designed for fewer leaf nodes (typically around 4, Letouze,
personal communication). It is worth stressing that, unlike its competitors, MEDICC is not linked to a
specific data collection platform. Data from SNP arrays can be used, as well as sequencing-based datasets
or any other method that returns absolute copy numbers.
Future work will focus on reductions of algorithmic complexity as well as the integration of SNP data into
the reconstruction process. Once this is achieved and sufficient curated training data is available, the FST
approach allows us to extend our approach to a full probabilistic model of cancer evolution.
Methods
SNP array data for the example from the OV03/04 study can be accessed at the NCBI Gene Expression
Omnibus under accession number GSE40546.
Simulation of tumour evolution
Coalescent trees were simulated using the APE R package [41]. Simulation of genome evolution on these
trees was performed by custom code, released as the SimCopy R package [40]. SimCopy relies on the
PhyloSim package [54] in order to perform the simulations on the level of abstract “genomic regions”. The
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genomic regions are encoded in a sequence of integers, with the sign representing their orientation. The
package then uses modified PhyloSim processes in order to simulate deletion, duplication, inversion,
inverted duplication and translocation events happening with rates specified by the user. The number of
genomic regions affected by each of these events is modelled by truncated Geometric+1 distributions. After
simulating genome evolution, CN profiles are reported for leaf and internal nodes. Genomes were simulated
using 15 leaf nodes, a root size of 100 segments and an average event length of 12 segments to allow for
overlapping events. Event rates covered the following set: 0.02, 0.03, 0.04, 0.05, 0.07, 0.1, 0.13, 0.15, 0.18, 0.2.
Individual event rates were modified with the following factors: deletions: 0.3, duplications: 1.0, inverted
duplications: 0.1, inversions: 0.2, translocations: 0.2. All parameters were chosen such that the leaf node
CN distributions are similar in shape to CN distributions from experimental data in the clinical study
Schwarz et al. 2013 (in prep.).
Implementation of MEDICC
All FST and FSA algorithms were implemented using OpenFST [37]. MEDICC was written in Python,
while implementation of time-critical parts used C. For the Fitch-Margoliash implementations we used the
Phylip package [55]. MEDICC is available at https://bitbucket.org/rfs/medicc and has been tested on
Windows and UNIX-based systems.
The quantitative analysis of MEDICC results was done in R and all necessary functions are implemented
in the MEDICCquant package included in the MEDICC distribution. Spatial statistics were computed
using the spatstat package [49], and for kernel manipulations the kernlab package was used [56].
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Figures
Figure 1 - Evolutionary CN trees are reconstructed in three steps
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Figure 1: Evolutionary CN trees are reconstructed in three steps: 1) After segmentation and
compression, major and minor alleles are phased using the minimum event criterion. 2) The tree topology is
reconstructed from the pairwise distances between genomes. 3) Reconstruction of ancestral genomes yields
the final branch lengths of the tree, which correspond to the number of events between genomes.
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Figure 2 - Efficient distance calculation is enabled via a transducer architecture
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Figure 2: Efficient distance calculation is enabled via a transducer architecture: A) Overlapping
genomic rearrangements modify the associated CN profiles in different ways. Amplifications are indicated
in green, deletions in red. The blue rectangles indicate the previous event. B) The one-step minimum event
transducer describes all possible edit operations achievable in one event. This FST is composed n times with
itself to create the the full minimum event FST T . Edge labels consist of an input symbol, a colon and the
corresponding output symbol, followed by a slash and the weight associated with taking that transition. C)
The minimum event FST T is asymmetric and describes the evolution of a genomic profile from its ancestor.
Composed with its inverse this yields the symmetric minimum event distance D.
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Figure 3 - Parental alleles are phased using context-free grammars
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Figure 3: Parental alleles are phased using context-free grammars: A) Allelic phasing is achieved
by choosing consecutive segments from either the major or minor allele which minimise the pairwise distance
between profiles. B) The set of all possible phasing choices is modelled by a context-free grammar. In
this representation, the order of the regions’ CN values on the second allele is reversed, in order to match
the inside-out parsing scheme of CFGs. That way every possible parse tree of the grammar describes one
possible phasing.
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Figure 4 - MEDICC improves reconstruction accuracy over competing methods
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Figure 4: MEDICC improves reconstruction accuracy over competing methods: A) Simulations
results show the improvement of reconstruction accuracy for MEDICC over naive methods (BioNJ clustering
on Euclidean distances between CN profiles, red) and competing algorithms (TuMult, green). B) Density
estimates of clonal expansion indices for neutrally evolving trees (red) and trees with induced long branches
as created by clonal expansion processes (blue) show the ability of MEDICC to detect clonal expansion.
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Figure 5 - MEDICC quantifies ITH from the locations of genomes on the mutational landscape
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Figure 5: MEDICC quantifies ITH from the locations of genomes on the mutational land-
scape: A) If no or a homogeneous selection pressure is applied, cells proliferate and die randomly across the
mutational landscape, leaving the surviving cells spatially unclustered. B) If the fitness landscape favours
specific mutations (blue shaded areas), genomes inside those areas are more likely to survive, those outside
more likely to die. The ability of a tumour for a clonal expansion into distant fitness pockets depends on
its mutation potential per generation (long orange arrow). This leads to C) a situation where distinct sub-
populations/clonal expansions are present in a tumour, indicating a generally high potential for a tumour to
adapt to changing environments. D) The mutational landscape additionally allows estimates of average dis-
tance between two subgroups of samples, here before (blue) and after (orange) chemotherapy. The distance
between the two subgroups is defined as the distance of the robust centres of mass (blue and orange X).
This robust centre of mass is computed omitting the single most distant point of each subgroup (blue and
orange samples in the orange and blue subgroups respectively), making the statistic more resistant towards
outliers.
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Figure 6 - Application to a case of endometrioid cancer
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Figure 6: Application to a case of endometrioid cancer: A) Evolutionary tree of the OV03-04 case
reconstructed from whole genome CN profiles. Approximate support values indicate how often each split
was observed in trees reconstructed after resampling of the distance matrix with added truncated Gaussian
noise. MEDICC performs reconstruction of ancestral CN profiles. Here, the (compressed) ancestral profiles
for chromosome 17 are given as an example and MEDICC depicts unresolved ambiguities in the form of
sequence logos. A star indicates no change compared to its ancestor. B) Ordination of the samples using
kPCA shows four clear clonal expansions, comprising three separate Omentum groups and the Bl/VV group.
C) Circos plot of selected genomic profiles (marked in bold in the tree) shows the extent of chromosomal
aberrations across the genome. The two phased parental alleles are indicated in red and blue.
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